Figure 5
Kaplan–Meier estimates of overall survival in advanced gastric cancer patients receiving docetaxel-based second-line chemotherapy according to (A) MMSET and (B) MMSET/BRCA1 mRNA levels.
Figure 5 | British Journal of Cancer
Kaplan–Meier estimates of overall survival in advanced gastric cancer patients receiving docetaxel-based second-line chemotherapy according to (A) MMSET and (B) MMSET/BRCA1 mRNA levels.
